International Journal of Radiation Oncology, Biology, Physics, Volume 97, Issue 5, 2017 Apr 1 | Philouze, Pierre, MD; Céruse, Philippe, MD, PhD
First, we would recommend induction chemotherapy (ICacrnm1) for this T3N2cM0 transglottic carcinoma. There is no exclusion from subsequent larynx-sparing therapy, there is a high risk of distant metastasis (N2c), and the treatment should start qui...
http://ift.tt/2o0Y1M9
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου